Join the Coagulation Defects and Disorders group to help and get support from people like you.
Coagulation Defects and Disorders News (Page 2)
Tenecteplase Has Similar Safety to TPA for Acute Ischemic Stroke
THURSDAY, Oct. 17, 2024 – For patients with acute ischemic stroke (AIS), tenecteplase (TNK) has improved functional outcome and reduced disability and similar safety to alteplase (tissue plasminogen...
Early Adoption of DOAC Dashboard Reduces Off-Label Prescribing
WEDNESDAY, Sept. 25, 2024 – Early adoption of the direct oral anticoagulant (DOAC) population management dashboard, the purpose of which includes pharmacist review and correction of off-label dosing...
Pomalidomide Efficacious in Hereditary Hemorrhagic Telangiectasia
MONDAY, Sept. 23, 2024 – For patients with hereditary hemorrhagic telangiectasia (HHT), pomalidomide yields a significant reduction in epistaxis severity, according to a study published in the Sept....
FDA Approves Rebinyn (Coagulation Factor IX (Recombinant), GlycoPEGylated) for Patients with Hemophilia B
PLAINSBORO, N.J., May 31, 2017 /PRNewswire/ – Novo Nordisk today announced that the U.S. Food and Drug Administration (FDA) has approved the Biologics License Application for Rebinyn (Coagulation...
FDA Approves Rixubis - First Recombinant Coagulation Factor IX For Use in Preventing Bleeding Episodes
June 27, 2013 – The U.S. Food and Drug Administration yesterday approved Rixubis [Coagulation Factor IX (Recombinant)] for use in people with hemophilia B who are 16 years of age and older. Rixubis...